Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Activity
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Regulatory
Riboflavin — INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE), INFUVITE PEDIATRIC
Application NDA021265
Riboflavin — INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE), INFUVITE PEDIATRIC
Application NDA021265
Riboflavin — INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE), INFUVITE PEDIATRIC
Application NDA021265
Riboflavin — INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE), INFUVITE PEDIATRIC
Application NDA021265
Riboflavin — INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE), INFUVITE PEDIATRIC
Application NDA021265
Riboflavin — INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE), INFUVITE PEDIATRIC
Application NDA021265
Riboflavin — INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE), INFUVITE PEDIATRIC
Application NDA021265
Riboflavin — INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE), INFUVITE PEDIATRIC
Application NDA021265
Riboflavin — PHOTREXA VISCOUS IN DEXTRAN 20%, PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA
Application NDA203324
Riboflavin — PHOTREXA VISCOUS IN DEXTRAN 20%, PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA
Application NDA203324
Riboflavin — INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE), INFUVITE PEDIATRIC
Application NDA021265
Riboflavin — PHOTREXA VISCOUS IN DEXTRAN 20%, PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA
Application NDA203324
Riboflavin — PHOTREXA VISCOUS IN DEXTRAN 20%, PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA
Application NDA203324
Riboflavin — INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE), INFUVITE PEDIATRIC
Application NDA021265
Riboflavin — EPIOXA HD/EPIOXA KIT
Application NDA219910
Riboflavin — PHOTREXA VISCOUS IN DEXTRAN 20%, PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA
Application NDA203324
Riboflavin — MULTIPLE VITAMINS INJECTION PEDIATRIC (PHARMACY BULK PACKAGE)
Application ANDA210456
Riboflavin — MULTIPLE VITAMINS INJECTION PEDIATRIC
Application ANDA210671
Riboflavin — MULTIPLE VITAMINS INJECTION ADULT
Application ANDA210273
Riboflavin — MULTIPLE VITAMINS INJECTION ADULT
Application ANDA210672
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)